Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-03-20

Clinical Trial Update: Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis [Phase 4]

View source ↗

Summary

A Phase 4 study from Beijing Chest Hospital is evaluating shortened regimens for drug-susceptible pulmonary tuberculosis, with the trial status currently listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Tuberculosis, Pulmonary | Phase 4 | Status: UNKNOWN